Ardent Health (NYSE:ARDT) Given Sell (D+) Rating at Weiss Ratings

Key Points

• Weiss Ratings has reaffirmed a "sell (D+)" rating for Ardent Health (NYSE:ARDT), indicating a negative outlook for the stock.
• While KeyCorp and Bank of America have recently lowered their target prices for Ardent Health's shares, analysts maintain a consensus rating of "Moderate Buy," with an average price target of $19.33.
• In its latest quarterly earnings, Ardent Health reported a EPS of $0.52, exceeding expectations and generating revenue of $1.65 billion, surpassing analyst projections.

Ardent Health (NYSE:ARDT - Get Free Report)'s stock had its "sell (d+)" rating reaffirmed by investment analysts at Weiss Ratings in a report released on Wednesday,Weiss Ratings reports.

A number of other equities analysts have also recently issued reports on ARDT. KeyCorp cut their target price on shares of Ardent Health from $24.00 to $20.00 and set an "overweight" rating for the company in a research report on Thursday, August 7th. UBS Group began coverage on shares of Ardent Health in a report on Wednesday, September 10th. They set a "buy" rating and a $17.00 price target for the company. Wall Street Zen upgraded shares of Ardent Health from a "buy" rating to a "strong-buy" rating in a report on Saturday, August 9th. Bank of America downgraded shares of Ardent Health from a "neutral" rating to an "underperform" rating and lowered their price target for the stock from $15.50 to $14.60 in a report on Wednesday, July 16th. Finally, JPMorgan Chase & Co. lowered their price target on shares of Ardent Health from $18.00 to $15.00 and set a "neutral" rating for the company in a report on Monday, August 11th. Nine investment analysts have rated the stock with a Buy rating, one has given a Hold rating and two have given a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $19.33.

Ardent Health Price Performance

Shares of NYSE ARDT traded up $0.01 during midday trading on Wednesday, hitting $14.63. The company had a trading volume of 308,751 shares, compared to its average volume of 400,780. The company has a quick ratio of 2.00, a current ratio of 2.13 and a debt-to-equity ratio of 0.66. Ardent Health has a twelve month low of $10.10 and a twelve month high of $20.72. The business has a 50-day simple moving average of $12.67 and a two-hundred day simple moving average of $13.02. The firm has a market capitalization of $2.09 billion, a price-to-earnings ratio of 8.08, a price-to-earnings-growth ratio of 6.43 and a beta of 0.39.

Ardent Health (NYSE:ARDT - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $0.52 EPS for the quarter, beating the consensus estimate of $0.30 by $0.22. The firm had revenue of $1.65 billion during the quarter, compared to analysts' expectations of $1.54 billion. Ardent Health had a net margin of 4.11% and a return on equity of 16.66%. Ardent Health has set its FY 2025 guidance at 1.730-2.01 EPS. Equities research analysts anticipate that Ardent Health will post 1.23 earnings per share for the current year.

Hedge Funds Weigh In On Ardent Health

Several institutional investors have recently modified their holdings of the company. Oliver Luxxe Assets LLC grew its position in shares of Ardent Health by 1.5% during the second quarter. Oliver Luxxe Assets LLC now owns 87,639 shares of the company's stock worth $1,197,000 after acquiring an additional 1,319 shares during the last quarter. Geode Capital Management LLC grew its position in shares of Ardent Health by 0.6% during the second quarter. Geode Capital Management LLC now owns 286,848 shares of the company's stock worth $3,918,000 after acquiring an additional 1,769 shares during the last quarter. CWM LLC grew its position in shares of Ardent Health by 990.6% during the second quarter. CWM LLC now owns 2,203 shares of the company's stock worth $30,000 after acquiring an additional 2,001 shares during the last quarter. The Manufacturers Life Insurance Company grew its position in shares of Ardent Health by 8.3% during the second quarter. The Manufacturers Life Insurance Company now owns 27,530 shares of the company's stock worth $376,000 after acquiring an additional 2,110 shares during the last quarter. Finally, Morse Asset Management Inc bought a new position in shares of Ardent Health during the first quarter worth about $36,000.

About Ardent Health

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.